Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
(2020)
Journal Article
Objectives: Evaluation of rituximab and glucocorticoids as therapy to induce remission after relapse in ANCA-associated vasculitis (AAV) in a prospective observational cohort of patients enrolled into the induction phase of the RITAZAREM trial. Me... Read More about Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis.